Introduction to Anthem Biosciences IPO
Anthem Biosciences Restricted is arising with its Preliminary Public Providing (IPO) which opens for subscription on July 14, 2025 and closes on July 16, 2025. The IPO is solely an Supply for Sale (OFS) of 5.96 crore shares, aggregating as much as ₹ 3,395 crore. The corporate is not going to obtain any proceeds from this difficulty. This IPO is drawing consideration because of its sturdy presence within the Contract Analysis, Improvement, and Manufacturing Group (CRDMO) house. On this article we might analyse and evaluate Anthem Biosciences IPO, Particulars, IPO Dates, Threat Components, Causes to speculate, GMP, Valuations and supply our view about this IPO.
About Anthem Biosciences Ltd
Included in 2006, Anthem Biosciences is a technology-driven CRDMO providing end-to-end options throughout drug discovery, improvement, and manufacturing. It supplies specialised fermentation-based APIs, probiotics, enzymes, peptides, and biosimilars to world purchasers in over 44 nations.
The corporate had 196 energetic tasks as of September 30, 2024, and a powerful buyer base together with over 550 purchasers, starting from rising biotech to massive pharma firms.
Aggressive Strengths
- Absolutely built-in CRDMO with presence throughout the drug life cycle.
- Concentrate on innovation with sturdy patent portfolio (7 abroad, 1 India, 24 pending).
- Sturdy world consumer base throughout 44+ nations.
- Skilled administration and strong R&D group (600+ scientists).
- Diversified income from CRDMO and specialty components companies.
Anthem Biosciences IPO Subject Particulars
- IPO Opening Date: July 14, 2025
- IPO Closing Date: July 16, 2025
- Itemizing Date: July 21, 2025 (Tentative)
- Worth Band: ₹ 540 – ₹ 570 per share
- Lot Dimension: 26 shares
- Minimal Funding: ₹ 14,820
- Worker Low cost: ₹ 50/share
- Complete Subject Dimension: ₹ 3,395 crore (OFS solely)
- Itemizing At: BSE and NSE
Financials of Anthem Biosciences
| Particulars | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income (Cr) | 1,133.99 | 1,483.07 | 1,930.29 |
| PAT (Cr) | 385.19 | 367.31 | 451.26 |
| EBITDA (Cr) | 446.05 | 519.96 | 683.78 |
| Internet Price (Cr) | 1,740.67 | 1,924.66 | 2,409.86 |
| ROE | – | – | 20.82% |
| ROCE | – | – | 26.88% |
| PAT Margin | – | – | 23.38% |
| EBITDA Margin | – | – | 36.81% |
| Debt/Fairness | – | – | 0.05 |
P/E Ratio and Peer Comparability
- EPS (FY25): ₹ 8.07
- P/E at higher worth band (₹ 570): ~70.62x
Friends: Most listed CRDMO firms in India commerce at excessive P/E because of restricted provide and world demand. Nevertheless, a P/E over 70x for this IPO suggests aggressive pricing.
Objects of the Subject
This IPO is an entire Supply for Sale, and no proceeds will go to the corporate. The whole quantity will likely be obtained by promoting shareholders.
Gray Market Premium (GMP) of Anthem Biosciences IPO
As of newest updates, the GMP is round ₹ 110-130, indicating a possible itemizing acquire of 20-23% over the higher band worth.
Causes to Put money into Anthem Biosciences IPO
- One in all India’s main CRDMO gamers.
- Sturdy income and revenue development.
- Low debt (D/E of 0.05), excessive ROE and ROCE.
- Diversified world consumer base.
- Possible itemizing good points as per present GMP.
Threat Components
- Solely an OFS; firm received’t obtain funds.
- Premium valuation with P/E ~70x.
- Excessive dependency on worldwide purchasers.
- Regulatory dangers associated to pharma manufacturing.
- No long-term steerage offered.
Methods to Apply for Anthem Biosciences IPO?
Traders can apply through:
- Internet banking utilizing ASBA (beneath IPO part)
- UPI by way of dealer platforms like Zerodha, Groww, Upstox
Guarantee UPI mandate is permitted earlier than 5 PM on July 16, 2025.
Conclusion: Must you Subscribe to Anthem Biosciences IPO or Keep away from?
Anthem Biosciences has proven sturdy monetary development and instructions a distinct segment place within the CRDMO house. Whereas the valuation seems premium, the strong fundamentals and powerful GMP counsel optimistic itemizing potential. Excessive-risk buyers with long-term view can Subscribe to this IPO. Conservative buyers might look forward to post-listing alternatives.
FAQs on Anthem Biosciences IPO
- What’s the Anthem Biosciences IPO date?
- The IPO opens on July 14, 2025, and closes on July 16, 2025.
- What’s the Anthem Biosciences IPO worth band?
- The worth band is ₹ 540 to ₹ 570 per share.
- What’s the minimal lot dimension for Anthem Biosciences IPO?
- Minimal lot is 26 shares, which quantities to ₹ 14,820.
- What’s the GMP of Anthem Biosciences IPO?
- As per the most recent, GMP is round ₹ 110-130.
- Is Anthem Biosciences IPO good for funding?
- It’s appropriate for high-risk buyers searching for long-term development within the biotech and pharma house.
- How a lot is the IPO dimension and construction?
- IPO dimension is ₹ 3,395 crore, and it’s a 100% Supply for Sale.
- When will Anthem Biosciences IPO be listed?
- Tentative itemizing date is July 21, 2025 on BSE and NSE.
Disclaimer: This text is for informational functions solely and never a advice or solicitation to purchase or promote any securities. The IPO evaluate is predicated on data accessible within the Pink Herring Prospectus (RHP) and different dependable sources on the time of writing. Readers are suggested to seek the advice of their monetary advisor earlier than making any funding determination. Myinvestmentideas.com or the writer just isn’t answerable for any losses incurred based mostly on this data.
Uncover extra from Myinvestmentideas.com
Subscribe to get the most recent posts despatched to your e mail.
